Marker Therapeutics (MRKR) Stock Insights

MRKR price $1.00 +0.05 +5.12%

Ticker
MRKR
Price
$1.00
Change
+0.05 +5.12%
Market cap ?
$16.67M
Beta ?
1.53
Sector
Healthcare
Industry
Biotechnology

Fair value

MRKR fair value $11.19. Price $1.00. Price is 91% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.62M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.5). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 16.67M. Net debt -16.07M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare MRKR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.12—2.12M
2026-08-14-0.09-0.13700.00K660.67K
2026-05-15-0.16-0.18800.00K783.90K
2026-03-18-0.10-0.211.10M682.10K
2025-11-13-0.12-0.361.23M723.00K
2025-08-14-0.29-0.30861.18K430.60K
2025-05-15-0.40-0.66349.10K174.55K
2025-03-31-0.42-0.222.25M1.22M
2024-11-14-0.26-0.391.93M1.00M
2024-08-14-0.29-0.431.17M—
2024-05-15-0.27-0.251.24M—
2024-03-26-0.48-1.001.06M—
2023-11-09-0.34-0.90257.61K—
2023-08-14-0.47-0.80762.66K—
2023-05-16-0.570.801.23M—
2023-03-22-0.48-1.00759.14K270.00K
2022-11-10-0.80-1.20999.57K400.00K
2022-08-11-1.10-1.27790.51K2.50M
2022-05-13-1.20-1.33964.32K1.00M
2022-03-17-1.20-1.271.24M—
2021-11-10-1.20-1.27——
2021-08-10-1.30-1.17——
2021-05-12-1.60-1.45——
2021-03-09-1.80-1.600—
2020-11-09-1.60-1.43——
2020-08-10-1.40-1.42466.79K466.79K
2020-05-11-1.40-1.14——
2020-03-12-1.10-1.26213.19K251.96K
2019-11-12-1.20-1.32——
2019-08-08-1.20-1.28——
2019-05-09-1.20-1.70——
2019-03-15-6.40-2.106—
2018-11-13-3.20-4.40——
2018-08-09-4.07—205.99K—
2018-05-15-3.01———
2018-03-23-3.00-5.00——
2017-11-14-3.90—183.06K—
2017-08-07-2.21———
2017-05-05-2.87———
2017-03-14-1.78———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2025-11-17Knobil KatharineBuy137.33K$0.95131.12K
2025-11-17Knobil KatharineBuy84.41K$0.9580.60K
2025-11-17Eansor Norman DavidBuy137.33K$0.95131.12K
2025-11-17Eansor Norman DavidBuy84.41K$0.9580.60K
2025-11-17ELMS STEVEBuy137.33K$0.95131.12K
2025-11-17ELMS STEVEBuy84.41K$0.9580.60K
2025-10-31Corzo Kathryn PenkusBuy147.61K$0.99145.80K
2025-10-31Vera JuanBuy250.00K$0.99246.93K
2025-10-31Corzo Kathryn PenkusOther0——
2025-02-12ELMS STEVEBuy30.00K$1.5947.70K
2025-02-12Knobil KatharineBuy30.00K$1.5947.70K
2025-02-12Eansor Norman DavidBuy30.00K$1.5947.70K
2025-02-12Vera JuanBuy50.00K$1.5979.50K
2024-12-23ELMS STEVEBuy11.09K$3.2035.47K
2024-12-23New Enterprise Associates 16, L.P.Buy554.25K$3.201.77M
2023-06-30Lurier Eliot MOther0——
2023-06-06Eansor Norman DavidBuy8.00K$1.7213.76K
2023-06-06Knobil KatharineBuy8.00K$1.7213.76K
2023-06-06Wilson John RobertBuy8.00K$1.7213.76K
2023-06-06ELMS STEVEBuy8.00K$1.7213.76K
2023-05-10Vera JuanBuy100.00K$1.42142.00K
2023-02-27Hoang Tsvetelina PBuy33.16K$2.1470.96K
2023-02-27Koneru MythiliBuy51.92K$2.14111.10K
2023-02-27Loiacono MichaelBuy38.48K$2.1482.35K
2023-02-27Vera JuanBuy46.49K$2.1499.48K
2023-02-27Szymanska AnnaBuy29.95K$2.1464.09K
2023-02-27Agopyan NadiaBuy34.15K$2.1473.09K
2022-05-24Wilson John RobertBuy80.00K——
2022-05-24Laskow-Pooley DavidBuy80.00K——
2022-05-24Knobil KatharineBuy80.00K$0.3427.02K
2022-05-24Knobil KatharineBuy80.00K——
2022-05-24ELMS STEVEBuy80.00K——
2022-05-24ELMS STEVEBuy80.00K$0.3427.02K
2022-05-24Eansor Norman DavidBuy80.00K——
2022-05-24Eansor Norman DavidBuy80.00K$0.3427.02K
2022-03-24Hoang Peter L.Buy199.09K——
2022-03-24Hoang Peter L.Sell48.38K$0.4823.45K
2022-03-24Vera JuanBuy140.82K——
2022-03-24Vera JuanSell33.47K$0.4816.22K
2022-03-24Kim Anthony H.Buy150.51K——
2022-03-24Kim Anthony H.Sell36.08K$0.4817.49K
2022-02-17Hoang Peter L.Buy430.00K$0.46197.80K
2022-02-17Vera JuanBuy160.00K$0.4673.60K
2022-02-17Szymanska AnnaBuy40.00K$0.4618.40K
2022-02-17Loiacono MichaelBuy140.00K$0.4664.40K
2022-02-17Koneru MythiliBuy160.00K$0.4673.60K
2022-02-17Kim Anthony H.Buy160.00K$0.4673.60K
2022-02-17Hoang Tsvetelina PBuy40.00K$0.4618.40K
2022-02-17Garrett GeraldBuy40.00K$0.4618.40K
2022-02-17Agopyan NadiaBuy40.00K$0.4618.40K
2021-12-08Knobil KatharineBuy125.00K$1.20150.00K
2021-12-08Knobil KatharineOther0——
2021-06-08Wasserman Frederick GeraldBuy12.66K——
2021-06-08Laskow-Pooley DavidBuy12.66K——
2021-06-08ELMS STEVEBuy12.66K——
2021-06-08Eansor Norman DavidBuy12.66K——
2021-06-08Wilson John RobertBuy12.66K——
2021-05-18Wasserman Frederick GeraldBuy10.00K$2.4124.10K
2021-03-25Eansor Norman DavidBuy7.14K——
2021-03-25Eansor Norman DavidSell14.29K——
2021-03-16Eansor Norman DavidBuy14.29K$17.50249.99K
2021-03-16Walker Paul EdwardBuy5.71M$1.7510.00M
2021-03-16Sonsini Peter W.Buy5.71M$1.7510.00M
2021-03-16SANDELL SCOTT DBuy5.71M$1.7510.00M
2021-03-16MAKOWER JOSHUABuy5.71M$1.7510.00M
2021-03-16Makhzoumi MohamadBuy5.71M$1.7510.00M
2021-03-16Florence Anthony A. Jr.Buy5.71M$1.7510.00M
2021-03-16Chang CarmenBuy5.71M$1.7510.00M
2021-03-16Behbahani AliBuy5.71M$1.7510.00M
2021-03-16BASKETT FORESTBuy5.71M$1.7510.00M
2021-03-16New Enterprise Associates 16, L.P.Buy5.71M$1.7510.00M
2021-03-16Wilson John RobertBuy1.71M$1.753.00M
2021-03-16Vera JuanBuy571.43K$1.751000.00K
2021-03-16Hoang Peter L.Buy142.86K$1.75250.00K
2021-03-16ELMS STEVEBuy1.14M$1.752.00M
2021-02-11Hoang Peter L.Buy430.00K$3.061.32M
2021-02-10Vera JuanBuy140.00K$3.29460.60K
2021-02-10Szymanska AnnaBuy40.00K$3.29131.60K
2021-02-10Loiacono MichaelBuy140.00K$3.29460.60K
2021-02-10Koneru MythiliBuy140.00K$3.29460.60K
2021-02-10Kim Anthony H.Buy160.00K$3.29526.40K
2021-02-10Hoang Tsvetelina PBuy40.00K$3.29131.60K
2021-02-10Garrett GeraldBuy40.00K$3.29131.60K
2021-02-10Agopyan NadiaBuy40.00K$3.29131.60K
2020-12-31Wilson John RobertOther0——
2020-12-31Wasserman Frederick GeraldOther0——
2020-12-31Laskow-Pooley DavidOther0——
2020-12-31ELMS STEVEOther0——
2020-12-31ELMS STEVEOther0——
2020-12-31Eansor Norman DavidOther0——
2020-11-09Eastern Capital LTDOther0——
2020-06-16Eastern Capital LTDSell416.67K$15.006.25M
2020-05-19Wilson John RobertBuy17.02K——
2020-05-19Wasserman Frederick GeraldBuy17.02K——
2020-05-19Laskow-Pooley DavidBuy17.02K——
2020-05-19ELMS STEVEBuy17.02K——
2020-05-19Eansor Norman DavidBuy17.02K——
2020-03-10Hoang Peter L.Buy388.80K$2.12824.26K
2020-03-10Hoang Peter L.Buy41.20K$2.1287.34K
2020-03-10Vera JuanBuy113.40K$2.12240.41K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 35, holders -1 vs prior quarter. Ownership 20.55%.

HolderSharesChangeChange %Value
NEA MANAGEMENT COMPANY, LLC1.63M00.00%2.39M
BLUE OWL CAPITAL HOLDINGS LP554.25K00.00%814.75K
VANGUARD CAPITAL MANAGEMENT LLC426.17K36.85K+9.47%626.47K
AISLING CAPITAL MANAGEMENT LP325.37K00.00%478.29K
RENAISSANCE TECHNOLOGIES LLC249.42K74.13K+42.29%366.65K
GEODE CAPITAL MANAGEMENT, LLC139.82K-21.09K-13.11%205.56K
OSAIC HOLDINGS, INC.112.65K19.53K+20.97%165.59K
VANGUARD FIDUCIARY TRUST CO87.27K00.00%128.28K
LPL FINANCIAL LLC83.15K100+0.12%122.23K
CONCURRENT INVESTMENT ADVISORS, LLC67.96K67.96KNew99.91K
TWO SIGMA INVESTMENTS, LP60.20K-800-1.31%88.50K
XTX TOPCO LTD45.36K-18.21K-28.65%66.67K
NORTHERN TRUST CORP34.63K8.62K+33.14%50.91K
CITADEL ADVISORS LLC32.52K32.52KNew47.80K
STATE STREET CORP20.95K00.00%30.79K
INVST, LLC18.00K-11.00K-37.93%26.46K
CREATIVE PLANNING17.31K00.00%25.45K
JANE STREET GROUP, LLC16.83K-19.47K-53.63%24.74K
ASHTON THOMAS PRIVATE WEALTH, LLC16.40K00.00%24.11K
VIRTU FINANCIAL LLC11.57K11.57KNew17.00K
FIFTH THIRD BANCORP10.00K00.00%14.70K
UBS GROUP AG8.15K-24.22K-74.82%11.98K
VANGUARD GLOBAL ADVISERS, LLC2.51K00.00%3.69K
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC2.00K00.00%2.90K
TOWER RESEARCH CAPITAL LLC (TRC)810-2.33K-74.18%1.19K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Marker Therapeutics (MRKR) Stock Insights

MRKR$1.00+0.05 +5.12%

$16.67M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History